JP2021046392A5 - - Google Patents

Download PDF

Info

Publication number
JP2021046392A5
JP2021046392A5 JP2020153558A JP2020153558A JP2021046392A5 JP 2021046392 A5 JP2021046392 A5 JP 2021046392A5 JP 2020153558 A JP2020153558 A JP 2020153558A JP 2020153558 A JP2020153558 A JP 2020153558A JP 2021046392 A5 JP2021046392 A5 JP 2021046392A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutical
cellulose
less
nanostructured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020153558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021046392A (ja
JP7640065B2 (ja
Filing date
Publication date
Priority claimed from EP19397527.3A external-priority patent/EP3791864A1/en
Application filed filed Critical
Publication of JP2021046392A publication Critical patent/JP2021046392A/ja
Publication of JP2021046392A5 publication Critical patent/JP2021046392A5/ja
Application granted granted Critical
Publication of JP7640065B2 publication Critical patent/JP7640065B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020153558A 2019-09-13 2020-09-14 医薬組成物を調製する方法及び医薬組成物 Active JP7640065B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19397527 2019-09-13
EP19397527.3A EP3791864A1 (en) 2019-09-13 2019-09-13 Method for preparing pharmaceutical composition and pharmaceutical composition

Publications (3)

Publication Number Publication Date
JP2021046392A JP2021046392A (ja) 2021-03-25
JP2021046392A5 true JP2021046392A5 (https=) 2023-08-10
JP7640065B2 JP7640065B2 (ja) 2025-03-05

Family

ID=67997550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020153558A Active JP7640065B2 (ja) 2019-09-13 2020-09-14 医薬組成物を調製する方法及び医薬組成物

Country Status (5)

Country Link
US (1) US11723867B2 (https=)
EP (1) EP3791864A1 (https=)
JP (1) JP7640065B2 (https=)
KR (1) KR20210032280A (https=)
CN (1) CN112494430B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3791858A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation
JP2021090882A (ja) * 2021-03-19 2021-06-17 株式会社三洋物産 遊技機
JP2021090883A (ja) * 2021-03-19 2021-06-17 株式会社三洋物産 遊技機
JP2021090879A (ja) * 2021-03-19 2021-06-17 株式会社三洋物産 遊技機
JP2021090881A (ja) * 2021-03-19 2021-06-17 株式会社三洋物産 遊技機
JP2021090884A (ja) * 2021-03-19 2021-06-17 株式会社三洋物産 遊技機
CN116764001B (zh) * 2023-06-29 2025-11-11 上海交通大学医学院附属第九人民医院 多孔碳基双载药纳米缓释材料及其子宫支架与应用
WO2025155702A1 (en) * 2024-01-19 2025-07-24 University Of Maine System Board Of Trustees Cellulose-based hydrogels as vaccine adjuvants
CN119528842B (zh) * 2024-10-25 2025-12-16 上海工程技术大学 一种通过氧化纳米纤维素调控药物晶型的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4308336B2 (ja) * 1997-03-14 2009-08-05 株式会社日本吸収体技術研究所 ミクロフィブリル状微細繊維構造体およびその製造方法
AU757605B2 (en) 1999-01-28 2003-02-27 Indevus Pharmaceuticals, Inc. Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
FI20095638A0 (fi) 2009-06-09 2009-06-09 Valtion Teknillinen Hydrofobiineja aktiivisten aineiden dispergointiin
FI123988B (fi) 2010-10-27 2014-01-31 Upm Kymmene Corp Soluviljelymateriaali
FI130619B (en) * 2011-11-15 2023-12-15 Upm Kymmene Corp Matrix for sustained delivery of bioactive agents
BR112015014523A2 (pt) 2012-12-19 2017-07-11 Kashiv Pharma Llc nanossuspensão estabilizada, composição farmacêutica, e, método de tratamento de um paciente
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibril polysaccharide for use in the control and prevention of constriction and scarring
CN103520739B (zh) 2013-10-22 2015-01-28 东北林业大学 一种纤维素纳米纤丝和吲哚美辛自组装复合体系的制备方法
FI126854B (en) * 2013-12-30 2017-06-30 Upm Kymmene Corp The membrane, its use and the method for making the membrane
JP6712875B2 (ja) 2016-03-04 2020-06-24 第一工業製薬株式会社 繊維芽細胞増殖促進剤
FI3922279T3 (fi) 2016-08-30 2025-02-04 Dana Farber Cancer Inst Inc Lääkkeenantokoostumuksia ja niiden käyttötapoja
EP3791858A1 (en) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injectable pharmaceutical formulation

Similar Documents

Publication Publication Date Title
JP2021046392A5 (https=)
CA2405072C (en) Gel compositions containing metronidazole
Rasenack et al. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs
CN1649603A (zh) 包含甲硝唑的含水组合物
RU2010138925A (ru) Микрочастица и ее фармацевтическая композиция
JP2003528914A (ja) カルベジロールの濃縮溶液
JP2021169504A (ja) アプレピタント経口液体製剤
RU2572693C2 (ru) Способ смачивания порошка, содержащего пероксид бензоила
AU2013357113B2 (en) Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
JP4378755B2 (ja) ブチルフタリドとシクロデキストリンまたはその誘導体との包接複合体、それらの調製のためのプロセスおよびその使用
JP6666352B2 (ja) デュタステリド含有固体分散体及びこれを含む組成物
CN107080745A (zh) 一种载叶黄素白蛋白纳米粒的口腔速溶膜及其制备方法
CN112107689A (zh) 一种小粒径多羟基中药活性成分纳米结晶的制备方法及其应用
KR20130102037A (ko) 트립토판 유도체를 함유하는 약학 조성물
JPWO2005094788A1 (ja) 難溶性薬物の微粒子分散液およびその製造方法
FR2907012A1 (fr) Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation
IL148725A (en) Aphrodisiac preparations containing cyclosonide
RU2019110218A (ru) Новые композиции на основе фуразидина и способы их изготовления
WO2014096740A1 (fr) Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoïque et de la gomme xanthane
WO2018111991A1 (en) Pharmaceutical composition containing celecoxib
EP2885265B1 (fr) Procede de fabrication de compositions riches en cristaux de mannitol sous forme delta
WO2017024953A1 (zh) 尼莫地平水溶性衍生物及其制备方法和应用
JP2024519421A (ja) カルバメート化合物を含む経口用水性懸濁液製剤
CN101773480B (zh) 含有多西他赛的纳米结晶制剂及其冻干剂的制备方法
EP1858494A2 (en) New soft gelatin capsules